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ABSTRACT: This Topical Review brieﬂy discusses selected
highlights of recent research on self-assembling peptide
amphiphiles (PAs) and polymer−peptide conjugates. Subjects
covered include new polymer chemistries used to prepare
polymer−peptide conjugates, PA self-assembly landscapes and
kinetics, developments in the application of bioactive PAs and
the relationship between self-assembly and bioactivity, novel
PA/biopolymer composites, functional π-stacking peptide
conjugates, use of enzymes to tune self-assembly, and
developments in high throughput methods and the design
and application of sequenced peptides.
1. INTRODUCTION
Peptide conjugates combine the biofunctionality and diverse
structural epitopes of peptides with nonpeptidic moieties such as
polymer or lipid chains, in order to adjust self-assembly behavior.
This enables access to nanostructures outside the range of
canonical peptide secondary and tertiary structures and leads to
the creation, for example, of ﬁbrillar, micellar, and vesicular
structures with high density peptide coatings. A large number of
therapeutically relevant applications are being uncovered for
such systems and this is driving ongoing intense research activity
in the ﬁeld.
This Topical Review highlights selected recent developments
in the ﬁeld of self-assembling peptide conjugates including
polymer−peptide conjugates, amphiphilic peptides, and peptide
amphiphiles (PAs). By its nature, it is not intended to be
comprehensive, and inevitably there is not suﬃcient space to
discuss all of the exciting progress in the ﬁeld. This Topical
Review complements a recent short review on bioactive
lipopeptides, focused on biologically derived, mainly cyclic
lipopeptides.1 In this review, we discuss developments in
polymer−peptide conjugates, in particular focused on the
synthesis of conjugates with alternatives to PEG [PEG:
polyethylene glycol]. Then we discuss the kinetics of self-
assembly and its relationship to the thermodynamic landscape.
This is followed by a brief summary of recent work in the highly
researched ﬁeld of bioactive peptide amphiphiles, which have
important potential biomedical applications, and on the
relationship between self-assembly and bioactivity and then of
PA/biopolymer composites. This is followed by brief accounts of
recent work on functional π-stacking peptide conjugates, the use
of enzymes to tune peptide self-assembly, high throughput
methods, and sequenced peptides.
The subjects of self-assembly of surfactant-like peptides and
peptide amphiphiles have recently been reviewed.2−6 In addition,
the formation of peptide nanotubes has been reviewed.7 On the
speciﬁc subject of PEG−peptide conjugates, a number of useful
reviews are available,8 as are a range of comprehensive reviews of
polymer−peptide conjugates more broadly.9−13
2. POLYMER−PEPTIDE CONJUGATES: BEYOND PEG
Although PEG has been widely used as a conjugating polymer
due to advantages in stability, low cost, and inertness, it can lead
to immunogenicity; it is not very biodegradable andmay undergo
peroxidation with damaging eﬀects for cells and tissues.14,15
PEGylation of proteins and peptides is performed in order to
increase circulation time in a “stealth”-like fashion. Therefore, a
variety of alternatives, prepared via living polymerization
methods, for example, have been considered, such as poly(2-
oxazoline)s, poly(N-hydroxypropyl methacrylamide), or oligo-
ethylene glycol methacrylates (OEGMAs) (Figure 1).14,15
An attractive and widely used set of methods to conjugate
polymers and peptides is so-called “click” reactions, including
copper-catalyzed alkyne−azide cycloaddition. This subject is
reviewed in detail elsewhere,16 and these and other methods to
synthesize PEG-peptides have been summarized.8 In one
interesting example, copper-catalyzed alkyne−azide cycloaddi-
tion has been combined in a single pot reaction with enzymatic
transamidation, which catalyzes acyl transfer between glutamine
and lysine residues, in order to prepare peptide conjugates.17 In
another recent study, direct thiol−ene coupling was used to
lipidate TLR (Toll-like receptor) agonist peptide CSK4, to
produce a self-adjuvating vaccine candidate.18
3. PA SELF-ASSEMBLY LANDSCAPES AND KINETICS
The thermodynamics and kinetics of self-assembly (and their
inter-relationships) of peptide-based systems such as PAs has
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been relatively unexplored until very recently. However, several
interesting reports suggest that this will be a rich ﬁeld for further
investigation. It has been reported that self-assembled β-sheet
ﬁbrils of a bioactive PA incorporating a sequence from the
extracellular matrix (ECM) proteoglycan lumican19 can
apparently be diluted below the equilibrium critical aggrega-
tion.20 Stability of the “crystallized” PA ﬁbrils and β-sheet
secondary structure for up to 1 week was observed, although
longer term kinetic and annealing studies are still ongoing. The
inﬂuence on bioactivity was also studied and a signiﬁcant increase
in collagen production by human corneal ﬁbroblasts was
observed for the diluted-aggregated system.20 Stupp’s group
have also observed kinetically trapped monodisperse long ﬁbers
with β-sheet structure and noted that this behavior was
dependent on ionic strength of the solution of the charged PA
molecules studied (Figure 2).21 The thermodynamically stable
state (accessed via annealing) at low ionic strength is short
monodisperse ﬁbrils with a random coil secondary structure. A
kinetically trapped state of long β-sheet ﬁbers can be accessed via
dilution from high ionic strength to below a critical ionic
strength. Re-annealing drives a transition back to the
thermodynamically stable state. At high ionic strength, an energy
barrier (obtained from an Arrhenius plot from temperature-
dependent rate kinetic measurements) separates the thermody-
namic product (monodisperse short ﬁbers without β-sheet
secondary structure) from a kinetically trapped state of long β-
sheet ﬁbers. This state is observed after annealing and dilution (in
that order), and the thermodynamic product can be accessed by
subsequent addition of salt to give high ionic strength conditions.
4. DEVELOPMENTS IN THE USE OF BIOACTIVE
PEPTIDE AMPHIPHILES
There continue to be remarkable developments in the
application of peptide amphiphiles to various biorelated
applications, including cell growth and diﬀerentiation. In one
example, Guler’s group produced nanoﬁbers containing mixtures
of PAs with GAG-mimetic functionality, a RGD cell adhesion
domain, or electrostatic diluent functionality.22 GAG denotes
glycosaminoglycan, a class of biomolecules with sulfonate,
hydroxyl, and carboxylate groups which are important
components of the extracellular matrix. Osteogenic or
chondrogenic diﬀerentiation of mesenchymal stem cells was
noted dependent on the concentration of media within the
bioactive PA nanoﬁber gels.22
Photodynamic control of bioactivity of PA nanoﬁbers has
recently been demonstrated.23 A PA was developed that contains
a photolabile linker between the RGDS cell adhesion sequence
and the rest of the PA molecule (lipopeptide with a peptide
sequence to drive β-sheet formation). Fibroblast spreading can
be arrested by exposure to light as a result of PA cleavage.23 In
another development, alginate-PA core−shell microparticles
have been prepared based on a cross-linked core of doxorubicin-
conjugated alginate coated with nanoﬁbers from a PA bearing
tumor-targeting folate units.24 Lack of space here prevents us
reviewing the other extensive seminal contributions of the Stupp
group to the study of PAs for biomedical applications. In any
case, this work has been reviewed by members of this group6,25,26
and is extensively featured in many other reviews on PAs.
In several types of tissue, the components of the extracellular
matrix such as collagen are aligned. It has been shown that
aligned PTFE [poly(tetraﬂuoroethylene)] substrates (having a
microgroove structure from controlled rubbing) enhance the
proliferation of aligned cells (Figure 3) and increase the
complexity of the produced tissue.27 An optimal composition
of mixtures of bioactive PA with “diluent” PA was identiﬁed
(13%:87% molar ratio), a composition similar to that identiﬁed
in prior work,6,28 which is possibly associated with optimal
epitope density.27 In a development of this work, self-releasing
aligned tissue ﬁlms were created based on protease degradation
of PAs incorporating MMP (matrix metalloprotease) sub-
strates.29,30 Tissue equivalents prepared on the aligned substrate
had highly ordered, compact collagen deposition, with a 2-fold
Figure 1. Examples of alternatives to PEG used in polymer−peptide
conjugates: (a) polyoxazolines, (b) poly(N-hydroxypropyl methacryla-
mide), (c) oligoethylene glycol methacrylates (OEGMAs).
Figure 2. Energy landscapes for self-assembling PAs.21 (a) Two ionic
strengths which modulate PA molecular electrostatic repulsion. (b)
Inﬂuence of dilution, annealing, and changes in ionic strength on the
mode of PA self-assembly. Reprinted by permission from Macmillan
Publishers Ltd.: Nature (ref 21), copyright 2016.
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higher elastic modulus compared to the less compact tissues
produced on the nonaligned template, the PA-coated glass.29
Another important application of peptide amphiphiles
involves their conjugation to bioactives such as drug molecules.
Cui et al. have investigated the formation of ﬁbrils or nanotubes
by a short β-sheet peptide derived from the Tau protein linked
via a short octyl spacer to the anticancer drug camptothecin.31
These nanostructures were shown to have antitumor activity
against a number of cancer cell lines. Following a similar concept,
camptothecin has been conjugated to a short yeast prion peptide
(Sup35) along with charged C terminal dipeptide units (two
lysine or two glutamic acid residues).32 The formation of
multiwalled nanotubes was observed in catanionic mixtures of
these peptide amphiphiles. This group has also investigated the
use of a PA containing a TAT [trans-activating transcriptional
activator] cell-penetrating peptide sequence (conjugated to four
octyl lipid chains) to encapsulate the hydrophobic anticancer
drug paclitaxel.33 A high loading eﬃciency was noted and
increased paclitaxel content led to increased nanoﬁber ﬂexibility.
They also showed that hydrophobic modiﬁcation (addition of a
palmitic acid chain) increased the uptake of a TAT peptide into
cancer cells and enhanced anticancer activity of a palmitoylated
TAT-doxorobicin conjugate compared to the conjugate without
the lipid chain.34
For practical applications, the control and stability of self-
assembled nanostructures under in vivo conditions is desirable.
In one example, it has recently been demonstrated that a
lipopeptide bearing anionic (glutamic acid-rich) sequences can
self-assemble into nanoﬁbers or micelles in blood serum.35 The
PA undergoes a transition from spherical micelles to nanoﬁbers
Figure 3. Enhanced cell adhesion on a mixed PA (C16-MMP/C16-ETTES, 13%:87% molar ratio) coating on alignment-inducing PTFE slides.
27 (a)
Schematic of PTFE and PTFE+PA coatings, uncoated glass was used as a control. (b) AFM mapping of PTFE and PTFE+PA coatings, with
representative cross-section scans. (c) Proliferation of hCSFs cultured at day 5 and day 12 on diﬀerent coatings. (d) Cell and corresponding (e) nucleus
and cytoskeleton orientation of hCSFs cultured for 12 days on PTFE, PTFE + PA, and uncoated glass surfaces using phase-contrast and ﬂuorescence
microscopy, respectively. Mean± S.D., n = 3 for all experiments. Scale bars: (d) 50 μm, (e) 10 μm. Reproduced in part from ref 27 with permission of the
Royal Society of Chemistry.
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in the pH range 7.0−7.4 in pure blood serum as shown by
ﬂuorescence anisotropy measurements on ﬂuorophore-labeled
PA molecules.
Another interesting application for peptide nanostructures is
in biomedical imaging. Recent highlights (pun intended) in the
literature include studies by the Cui and Stupp groups. A peptide-
basedmolecular beacon system has been developed that is able to
detect the enzyme cathepsin B due to cleavage of a short
substrate sequence and concomitant release of a pendant
ﬂuorophore (otherwise quenched due to the presence of a
quencher also incorporated in the molecule).36 The peptide also
incorporates a TAT sequence to facilitate uptake into cells. The
peptide conjugate self-assembles into micelles, but upon dilution
or pH triggering, the monomeric state is accessed and in this
form enzyme detection is possible due to exposure of the enzyme
degradable linker and ﬂuorophore. A similar peptide conjugate
but containing a β-sheet forming heptapeptide sequence (from
an amyloid peptide) is able to form spherical micelles or
nanoﬁbers (depending on temperature).37 The spherical form is
more readily taken up into cancer cells via endocytosis,
permitting in cellulo imaging. The Cui group has also developed
dual-mode nanoprobes containing both a ﬂuorophore for optical
imaging and a metal ion [Gd(III)] chelator for MRI or
radionuclear imaging.38 The nanoprobes are based on a PA to
which both probe groups are attached to lysine residues close to
the one or two alkyl chains in the molecules. The molecules self-
assemble into nanospheres. This incorporation of Gd-chelators
into PAs builds on earlier work on the development of PAs
bearing Gd(III) complexes for in situ MRI imaging of the uptake
(using a mouse leg model) and for subsequent tracking of the
biomaterial after implantation.39 In this work, the Gd complex
was attached, either singly or multiply, at the C-terminus to PAs
that self-assemble into nanoﬁbers.
5. RELATIONSHIP BETWEEN SELF-ASSEMBLY AND
BIOACTIVITY
The inﬂuence of self-assembly on bioactivity has been relatively
unexplored to date, at least in terms of studies where bioactivity
has been compared for PA in self-assembled and monomeric
states. However, a number of recent studies have examined the
inﬂuence of the shape of self-assembled nanostructures on
bioactivity.
The shape of self-assembled peptide nanostructures is known
to have an eﬀect on various properties, and recent work has
investigated the inﬂuence of shape on bioactivity. An earlier
review touches on this topic.40 It is well-known that the shape of
micelles (spherical vs rod-like) can inﬂuence in vivo delivery
properties of therapeutic molecules such as block copolymer self-
assemblies trapping drugs,41 and recent work has extended this
concept to PA systems. In one recent study,42 three PAs were
prepared with collagen-binding sequences. In one, a β-sheet
driving sequence (alternating A2V2 sequence) was included
which led to self-assembly into nanoﬁbers in contrast to the
spherical micelle assembly of the other two without the A2V2
sequence. Nanoﬁbers were shown to bind to a biological target
(rat carotid artery injury model) in contrast to the nanospheres.
In another very interesting recent study,43 nanoﬁbers formed by
a PA (with a β-sheet forming sequence) were compared to
nanospheres formed by related PAs (with proline sequence
disfavoring β-sheet formation) in terms of delivery of
oligonucleotides (incorporated into the PA nanostructures)
into cells. Distinct delivery mechanisms were observed depend-
ing on shape and size (which in fact are hard to decouple).
Nanoﬁbers were found to deliver more oligonucleotides into
cells when examined over an extended period, due to slow
diﬀusion of nanospheres out of cells despite their rapid initial
uptake. This group also compared some of the same PA
nanostructures in terms of delivery of a DNA sequence within
the class of pathogen-associated molecular patterns (PAMPs)
characteristic of bacteria and viruses.44 The authors showed that
nanoﬁbers exhibited enhanced uptake compared to nanospheres
or the DNA in the absence of any PA assemblies. This work
suggests that such structures may be useful in modulating the
immune response. A study on self-assembling star polymers with
a glycopeptide headgroup showed self-assembly into nanorods,
polymersomes, or micelles, depending on the polymer
composition.45 Rods and polymersomes were taken up by breast
cancer cells, although in contrast to the studies mentioned above,
no signiﬁcant eﬀect of the shape of the nanostructure on this
uptake was noted.
Alternatively, considering whether the monomer or aggre-
gated form is more bioactive, in one recent study it was reported
that lipid A (the lipid part of lipopolysaccharide, LPS, from E.
coli) forms small aggregates, and these show bioactivity (tumor
necrosis factor TNFα production cell assays), whereas monomer
does not.46 Earlier reports provided conﬂicting results. Whereas
Shnyra et al. reported that aggregated LPS shows enhanced
endotoxic activity compared to less aggregated form,47
Takayama et al. found enhanced stimulating activity of LPS in
a disaggregated monomeric state.48,49 Although this work is on
nonpeptide systems, related lipopeptides are also involved in
immune response and it will be interesting to examine whether
there is any diﬀerence in bioactivity of aggregated vs monomeric
forms of such peptide conjugates.
Our group recently showed that the aggregation state of Toll-
like (TLR) receptor agonist lipopeptides depends on the number
of palmitoyl lipid chains attached to the hexapeptide sequence
CSK4,
50 although this has not yet been correlated to bioactivity.
The lipopeptides with one or two lipid chains self-assembled into
spherical micelles with a disordered peptide conformation,
whereas the variant with three lipid chains forms a population of
ﬂexible nanotape structures based on β-sheet bilayers. In another
study, it was shown that the association number of micelles
formed by liraglutide, a lipidated glucagon-like peptide 1 (GLP-
1) agonist, is pH-dependent, although this was not correlated to
bioactivity.51
6. PA/BIOPOLYMER COMPOSITES
The potential to combine the properties of PAs and peptides
with those of biopolymers (e.g., structural and mechanical
properties, ready availability) has begun to be investigated,
leading to the creation of novel hybrid biomaterials with
remarkable and unique structural and functional properties.
Hybrid systems examined in early studies include PAs with
polysaccharides,52−55 PAs with recombinant structural pro-
teins,56 or amyloid peptides.57 Also recently studied are hybrid
materials from PAs with polysaccharides such as sodium alginate
including graphene oxide in the system to provide novel and/or
enhanced properties (structural, mechanical, electronic).58−61
Stupp and co-workers reported the ﬁrst observation of
membrane sac formation at the interface of aqueous solutions
of high-molecular-weight polysaccharide (hyaluronic acid) and a
cationic designer PA.52 The membrane formation was proposed
to result from the formation of a PA ﬁbril network diﬀusion
barrier, leading to polysaccharide nanoﬁbril bundle growth
perpendicular to the interface.52 The sacs enclosing PA gel were
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found to support stem cell growth and slow release of
encapsulated proteins. In subsequent work, the mechanical
properties and membrane permeability were examined in more
detail.53 Membranes formed by PAs bearing the KLAKLAK
sequence (with anticancer activity) mixed with hyaluronic acid
were also fabricated and their cytotoxicity toward breast cancer
cells was examined.54 A change in PA aggregate structure from
cylindrical ﬁbrils to spheres was also noted for this system.54
Membranes formed by complexation of a PA bearing a heparin-
binding sequence with several polysaccharides (including
heparin) have been prepared and their structure probed by
SAXS and electron microscopy.55 Interestingly, in some cases,
evidence for cubic phase structure within the membrane instead
of lamellar or hexagonal ordering was observed.55 Recently, Mata
and co-workers have demonstrated that complexation of cationic
PAs with elastin-like peptides produces robust membranes with
remarkable mechanical properties including the ability to draw
outmembrane tubes, and to extend tubules from the tube walls.56
Thesematerials could be used to create substrates able to support
stem cell growth, showing their great potential in tissue
engineering applications.56 Our group has recently prepared
hybrids of a cationic PA with sodium alginate, and soft or hard
capsules could be fabricated depending on the incorporation of
graphene oxide.62 Addition of sodium alginate leads to a
transition from micelles, which the PA molecules form on their
own, into bilayer structures which comprise the structural motif
of macroscopic membrane structures. A novel mechanism of
membrane formation is proposed. These materials also have
interesting antimicrobial properties.62
7. FUNCTIONAL π-STACKING PEPTIDE CONJUGATES
There has been a considerable amount of research on peptide
conjugates with bulky N-terminal substituents, which among
other interesting properties are able to form hydro- and organo-
Figure 4. Structure of compounds 1 and 2 studied by Banerjee’s group,67 an equimolar mix of which in o-dichlorobenzene emits white light. Reproduced
in part from ref 67 with permission of the Royal Society of Chemistry.
Figure 5. Intracellular esterase transforms a D-peptide−taurine conjugate (with N-terminal ﬂuorophore) into an aggregating molecule, which forms
ﬁbrils accumulating inside cells.71 Reprinted with permission from ref 71, Copyright 2015 American Chemical Society.
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gels. The aggregation properties of these molecules are enhanced
by π-stacking interactions of the N-terminal substituents such as
Fmoc [Fluorenylmethyloxycarbonyl] or naphthalene. Since this
subject has been recently reviewed by several groups,2,63−65 all
this prior work is not discussed again here. In one recent
impressive example, Banerjee’s group has developed gelators
based on a naphthalene diimide core with symmetrically attached
alkylated peptides, and showed that the ﬂuorescence properties
change upon formation of J-aggregate structures.66 In another
development, they discovered a two-component peptide-based
system exhibiting white light emission.67 This was observed for
mixtures of 1 and 2 (Figure 4) where 1 contains a stilbene
electron-donating moiety, and 2 contains a perylene diimide
electron acceptor. An equimolar mixture of 1 and 2 in o-
dichlorobenzene produces white light.67
It has recently been shown that conjugation of the ﬂuorophore
FITC [ﬂuorescein isothiocyanate] to the simple dipeptide
dileucine produces a cyto-compatible conjugate that is taken
up by dermal or corneal ﬁbroblasts in contrast to FITC itself.68
Co-localization imaging experiments show that FITC-LL
segregates in peri-nuclear and intracellular vesicle regions.
8. USE OF ENZYMES TO TUNE SELF-ASSEMBLY
Enzymes are natural catalysts, and being proteins, their binding
sites are peptide sequences and their substrates can also be
proteins or peptides. Recently, attention has been focused on the
use of enzymes to tune the self-assembly of peptide-based
materials. Xu’s group pioneered the use of enzymes to modulate
the hydrophobicity of peptide conjugates such that they self-
assemble into ﬁbrils (which can in turn entangle to form
hydrogels). A variety of enzymes including phosphatases/kinases
or thermolysin or esterases among others can be used for this
purpose. Ulijn’s group and others have made extensive use of this
concept, using for example esterases such as subtilisin to link
Fmoc-peptide methyl esters (and other similar conjugates with
bulky hydrophobic N-terminal units) and peptides into ﬁbril-
forming gelators. Thermolysin has also been used by this group
to link short Fmoc-peptides with uncapped C termini to methyl
esters of amino acids. This work has been reviewed else-
where.69,70
The Xu group has recently shown that intracellular esterase
can be used to drive the aggregation of a conjugate of taurine (2-
aminoethanesulfonic acid), with a peptide such as a short D-
amino acid peptide (resistant to proteolysis) via breakage of the
ester linkage between taurine and peptide in vivo. Aggregation
enhances cellular uptake (in fact it reduces cellular eﬄux of the
aggregated form, Figure 5).71 This is only one example of a great
deal of interesting recent work from this group, but unfortunately
lack of space prohibits further discussion herein. Exploiting a
similar concept, a lipopeptide susceptible to degradation by the
cancer-related enzyme matrix metalloprotease 7 (MMP-7)
aggregates to form a ﬁbrillar hydrogel upon endogenous
MMP-7 cleavage within cancer cells.72 This leads to signiﬁcant
cancer cell death.
In a subtle demonstration of the power of enzymatic
biotransformations, Gianneschi’s group showed that enzymatic
farnesyl transfer to peptides leads to PAs that self-assemble into
ﬁbrils.73 The farnesyl group was transferred from a farnesyl-coA
conjugate using a phosphopantetheinyl transferase (Figure 6).
The serine protease α-chmyotrotrypsin can be used to cleave a
Phe-containing lipopeptide C16−KKFFVLK at the aromatic
residues.74 The parent PA self-assembles into helically twisted
ribbons (and nanotubes),75 but the cleaved PAs C16−KKF and
C16−KKFF form small spherical micelles.74 The enzyme elastase
can be used to break up hydrogels formed by the self-assembly of
the model surfactant-like alanine-rich peptide KA6E, which forms
hydrogels containing tape-like ﬁbrils.76
9. HIGH THROUGHPUT METHODS
High throughput methods oﬀer a means to eﬃciently and
rationally assess properties of a peptide or peptide amphiphile,
such as bioactivity (e.g., cytocompatibility) or physical proper-
ties. In a pioneering work, Ulijn’s group have screened all 8000
(203) tripeptides (based on combinations of natural amino acids)
for their ability to form hydrogels.77 This led to the identiﬁcation
of several novel tripeptides able to form hydrogels at neutral pH.
High throughput methods, which are already extensively used to
synthesize and screen peptide-based materials, are likely to be
powerful tools in the future in assessing the aggregation
properties and bioactivities of various classes of peptide
conjugates.
10. SEQUENCED PEPTIDES
The term sequenced peptides here refers to alternating or bola-
amphiphilic peptides, although one class of such molecules
comprises both features, i.e., an alternating peptide central
sequence ﬂanked by terminal charged residues, termed multi-
domain peptides (MDPs) by the Hartgerink group.78 The
aggregation properties of sequenced peptides and bola-
amphiphilic peptides has recently been investigated by several
groups and a review on this topic was published in 2015.79
However, there have been subsequent interesting papers brieﬂy
highlighted here. The alternating peptide RFRFRFRF self-
assembles into very well ordered β-sheet ﬁbrils.80 The peptide
Figure 6. Process for farnesylation of peptide and self-assembled motif
of Far-peptide 5 compared to micelles of Far-CoA (4).73 The starting
material is a farnesyl−pantetheine conjugate (1) which is phosphory-
lated by Kinase 1 to generate 2 which in turn is adenylated using an
adenyl transferase to generate the dephospho-Far-CoA 3. Following
phosphorylation of 3 with Kinase 2, 4 was formed which spontaneously
self-assembles into spherical micelles. Transfer of the farnesyl group
onto Peptide 1 (an 11-amino-acid fragment of the natural protein
substrate for PPTase enzymes) was achieved via recognition of the
pantetheine adaptor molecule, leading to 5 which self-assembles into
ﬁbrils. Reprinted with permission from ref 73, Copyright 2015 American
Chemical Society.
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produces a highly aligned and feature-ﬁlled ﬁber X-ray diﬀraction
pattern which permits a structural model to be proposed, and
alignment of solutions under ﬂow was also observed by SAXS.80
In the category of bola-amphiphiles, the peptide RFL4FR forms
nanosheets and ﬁlms of this peptide can support the growth of
ﬁbroblasts.81 The anionic analogue EFL4FE forms nanotubes
instead which slowly develop in aqueous solution over a period of
days.82
11. CONCLUSIONS
This Topical Review has focused on several interesting recent
developments in the ﬁeld of self-assembling peptide conjugates.
In the space available, a comprehensive review was not possible
and we have highlighted instead a few examples of recent papers
(mainly from the last 3−4 years) that attracted our attention as
they report novel and/or signiﬁcant developments, likely to
impact on research in this ﬁeld. There are many other fascinating
challenges in exploiting this remarkable class of self-assembling
molecule for future applications in biomedicine and bioengineer-
ing among others. We keenly anticipate new discoveries as this
ﬁeld moves forward.
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